• Charity News

Why you need to ‘opt in’ to keep hearing from Cancer Research UK

Cancer Research UK is becoming an 'opt-in' charity - but what exactly does that mean for you and the way we work? Cancer Research UK is becoming an 'opt-in' charity - but what exactly does that mean for you and the way we work?

30 June 2017

• Health & Medicine

Large health inequalities across England revealed

There are stark differences in how long people in different parts of England can expect to live a healthy life, according to a new report. There are stark differences in how long people in different parts of England can expect to live a healthy life, according to a new report.

30 June 2017

• Health & Medicine

More than a quarter of women missing smear tests are unaware they exist

More than a quarter (28 per cent) of women who are overdue for a smear test don’t know about the cervical screening programme. More than a quarter (28 per cent) of women who are overdue for a smear test don’t know about the cervical screening programme.

30 June 2017

• Health & Medicine

CRT’s Discovery Laboratories extends alliance with Merck to develop new cancer drugs

Cancer Research Technology has signed a further deal with Merck to discover new cancer drugs targeting the Hippo pathway. Cancer Research Technology has signed a further deal with Merck to discover new cancer drugs targeting the Hippo pathway.

29 June 2017

• Science & Technology
• Health & Medicine

Lung cancer discovery points to a better way to personalise immunotherapy

New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t. New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.

27 June 2017

• Science & Technology
• Health & Medicine

New bladder cancer therapy to start clinical trials

An experimental treatment for bladder cancer will move into an early phase clinical trial under an agreement signed today. An experimental treatment for bladder cancer will move into an early phase clinical trial under an agreement signed today.

26 June 2017

• Science & Technology
• Health & Medicine

News digest – 8 new grand cancer challenges, blood tests, personalising immunotherapy and… ‘go natural’?

8 new Grand Challenges in cancer research launched, blood tests for prostate cancer, making immunotherapy more personal and… ‘go natural’? Here’s our weekly news digest. 8 new Grand Challenges in cancer research launched, blood tests for prostate cancer, making immunotherapy more personal and… ‘go natural’? Here’s our weekly news digest.

24 June 2017

• Health & Medicine

Tumour characteristics could predict immunotherapy success in lung cancer

The molecular make-up of lung tumours could help identify patients who might benefit from immunotherapy treatment up front, a new study has found. The molecular make-up of lung tumours could help identify patients who might benefit from immunotherapy treatment up front, a new study has found.

23 June 2017

• Science & Technology
• Health & Medicine

8 new challenges between us and beating cancer

We launch phase 2 of our Grand Challenge with 8 of the biggest questions in cancer research. We launch phase 2 of our Grand Challenge with 8 of the biggest questions in cancer research.

22 June 2017

• For Supporters

Cancer Research UK sets out latest £20m Grand Challenges to beat cancer sooner

Cancer Research UK launches the second phase of its global Grand Challenge, with eight new questions identified as some of the biggest barriers to progress. Cancer Research UK launches the second phase of its global Grand Challenge, with eight new questions identified as some of the biggest barriers to progress.

22 June 2017

• Charity News

Cancer Research UK appoints Professor Charles Swanton as its chief clinician

Cancer Research UK is pleased to announce the appointment of Professor Charles Swanton as its new chief clinician. Cancer Research UK is pleased to announce the appointment of Professor Charles Swanton as its new chief clinician.

21 June 2017

• Science & Technology
• Health & Medicine

Study estimates breast and ovarian cancer risk linked to faulty BRCA genes

A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer. A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.

20 June 2017